Global Anti-CD47 Antibody Supply, Demand and Key Producers, 2024-2030
The global Anti-CD47 Antibody market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
The industry trend of Anti-CD47 Antibody is highly promising and gaining significant attention in the field of cancer research and drug development. Several pharmaceutical companies and research institutions are actively pursuing the development of Anti-CD47 Antibody-based therapies. There is a growing interest in combining this antibody with other immuno-oncology agents, such as checkpoint inhibitors, to enhance its therapeutic efficacy. Clinical trials evaluating the safety and efficacy of Anti-CD47 Antibody treatments in various cancer types are ongoing and showing encouraging results. The advancement of precision medicine and personalized cancer therapies further supports the potential of Anti-CD47 Antibody as a valuable addition to the oncology treatment armamentarium.
An Anti-CD47 Antibody is a type of antibody that targets the CD47 protein, which is overexpressed in various types of cancer cells. CD47 acts as a "don't eat me" signal, preventing the immune system's macrophages from engulfing and destroying cancer cells. The Anti-CD47 Antibody works by blocking the CD47 protein, thereby allowing the immune system to recognize and eliminate cancer cells effectively. This antibody has shown promise as a potential therapeutic agent in cancer immunotherapy, as it enhances the body's natural immune response against cancer while minimizing toxic side effects.
This report studies the global Anti-CD47 Antibody demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Anti-CD47 Antibody, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Anti-CD47 Antibody that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Anti-CD47 Antibody total market, 2019-2030, (USD Million)
Global Anti-CD47 Antibody total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Anti-CD47 Antibody total market, key domestic companies and share, (USD Million)
Global Anti-CD47 Antibody revenue by player and market share 2019-2024, (USD Million)
Global Anti-CD47 Antibody total market by Type, CAGR, 2019-2030, (USD Million)
Global Anti-CD47 Antibody total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global Anti-CD47 Antibody market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BosterBio, Leinco Technologies, Bioss, Novus Biologicals, Thermo Fisher Scientific, Biorbyt, Abbexa, Bio X Cell and GeneTex, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Anti-CD47 Antibody market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Anti-CD47 Antibody Market, By Region:
1. How big is the global Anti-CD47 Antibody market?
2. What is the demand of the global Anti-CD47 Antibody market?
3. What is the year over year growth of the global Anti-CD47 Antibody market?
4. What is the total value of the global Anti-CD47 Antibody market?
5. Who are the major players in the global Anti-CD47 Antibody market?
The industry trend of Anti-CD47 Antibody is highly promising and gaining significant attention in the field of cancer research and drug development. Several pharmaceutical companies and research institutions are actively pursuing the development of Anti-CD47 Antibody-based therapies. There is a growing interest in combining this antibody with other immuno-oncology agents, such as checkpoint inhibitors, to enhance its therapeutic efficacy. Clinical trials evaluating the safety and efficacy of Anti-CD47 Antibody treatments in various cancer types are ongoing and showing encouraging results. The advancement of precision medicine and personalized cancer therapies further supports the potential of Anti-CD47 Antibody as a valuable addition to the oncology treatment armamentarium.
An Anti-CD47 Antibody is a type of antibody that targets the CD47 protein, which is overexpressed in various types of cancer cells. CD47 acts as a "don't eat me" signal, preventing the immune system's macrophages from engulfing and destroying cancer cells. The Anti-CD47 Antibody works by blocking the CD47 protein, thereby allowing the immune system to recognize and eliminate cancer cells effectively. This antibody has shown promise as a potential therapeutic agent in cancer immunotherapy, as it enhances the body's natural immune response against cancer while minimizing toxic side effects.
This report studies the global Anti-CD47 Antibody demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Anti-CD47 Antibody, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Anti-CD47 Antibody that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Anti-CD47 Antibody total market, 2019-2030, (USD Million)
Global Anti-CD47 Antibody total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Anti-CD47 Antibody total market, key domestic companies and share, (USD Million)
Global Anti-CD47 Antibody revenue by player and market share 2019-2024, (USD Million)
Global Anti-CD47 Antibody total market by Type, CAGR, 2019-2030, (USD Million)
Global Anti-CD47 Antibody total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global Anti-CD47 Antibody market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BosterBio, Leinco Technologies, Bioss, Novus Biologicals, Thermo Fisher Scientific, Biorbyt, Abbexa, Bio X Cell and GeneTex, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Anti-CD47 Antibody market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Anti-CD47 Antibody Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Monoclonal Antibody
- Polyclonal Antibody
- Biotechnology
- Medical
- University
- Others
- BosterBio
- Leinco Technologies
- Bioss
- Novus Biologicals
- Thermo Fisher Scientific
- Biorbyt
- Abbexa
- Bio X Cell
- GeneTex
- R&D Systems
- LSBio
- MyBioSource
- ProSci
- antibodies-online
- ABclonal Technology
- Abnova Corporation
- G Biosciences
- BioLegend
- Bio-Rad
- Huabio
- BPS Bioscience
- OriGene Technologies
- St John's Laboratory
- Absolute Antibody
- NSJ Bioreagents
- Cell Signaling Technology
- RayBiotech
- Beijing Solarbio Science & Technology
- Bethyl Laboratories
- Abeomics
1. How big is the global Anti-CD47 Antibody market?
2. What is the demand of the global Anti-CD47 Antibody market?
3. What is the year over year growth of the global Anti-CD47 Antibody market?
4. What is the total value of the global Anti-CD47 Antibody market?
5. Who are the major players in the global Anti-CD47 Antibody market?
1 SUPPLY SUMMARY
1.1 Anti-CD47 Antibody Introduction
1.2 World Anti-CD47 Antibody Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Anti-CD47 Antibody Total Market by Region (by Headquarter Location)
1.3.1 World Anti-CD47 Antibody Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Anti-CD47 Antibody Market Size (2019-2030)
1.3.3 China Anti-CD47 Antibody Market Size (2019-2030)
1.3.4 Europe Anti-CD47 Antibody Market Size (2019-2030)
1.3.5 Japan Anti-CD47 Antibody Market Size (2019-2030)
1.3.6 South Korea Anti-CD47 Antibody Market Size (2019-2030)
1.3.7 ASEAN Anti-CD47 Antibody Market Size (2019-2030)
1.3.8 India Anti-CD47 Antibody Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Anti-CD47 Antibody Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Anti-CD47 Antibody Major Market Trends
2 DEMAND SUMMARY
2.1 World Anti-CD47 Antibody Consumption Value (2019-2030)
2.2 World Anti-CD47 Antibody Consumption Value by Region
2.2.1 World Anti-CD47 Antibody Consumption Value by Region (2019-2024)
2.2.2 World Anti-CD47 Antibody Consumption Value Forecast by Region (2025-2030)
2.3 United States Anti-CD47 Antibody Consumption Value (2019-2030)
2.4 China Anti-CD47 Antibody Consumption Value (2019-2030)
2.5 Europe Anti-CD47 Antibody Consumption Value (2019-2030)
2.6 Japan Anti-CD47 Antibody Consumption Value (2019-2030)
2.7 South Korea Anti-CD47 Antibody Consumption Value (2019-2030)
2.8 ASEAN Anti-CD47 Antibody Consumption Value (2019-2030)
2.9 India Anti-CD47 Antibody Consumption Value (2019-2030)
3 WORLD ANTI-CD47 ANTIBODY COMPANIES COMPETITIVE ANALYSIS
3.1 World Anti-CD47 Antibody Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Anti-CD47 Antibody Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Anti-CD47 Antibody in 2023
3.2.3 Global Concentration Ratios (CR8) for Anti-CD47 Antibody in 2023
3.3 Anti-CD47 Antibody Company Evaluation Quadrant
3.4 Anti-CD47 Antibody Market: Overall Company Footprint Analysis
3.4.1 Anti-CD47 Antibody Market: Region Footprint
3.4.2 Anti-CD47 Antibody Market: Company Product Type Footprint
3.4.3 Anti-CD47 Antibody Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Anti-CD47 Antibody Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Anti-CD47 Antibody Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Anti-CD47 Antibody Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Anti-CD47 Antibody Consumption Value Comparison
4.2.1 United States VS China: Anti-CD47 Antibody Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Anti-CD47 Antibody Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Anti-CD47 Antibody Companies and Market Share, 2019-2024
4.3.1 United States Based Anti-CD47 Antibody Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Anti-CD47 Antibody Revenue, (2019-2024)
4.4 China Based Companies Anti-CD47 Antibody Revenue and Market Share, 2019-2024
4.4.1 China Based Anti-CD47 Antibody Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Anti-CD47 Antibody Revenue, (2019-2024)
4.5 Rest of World Based Anti-CD47 Antibody Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Anti-CD47 Antibody Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Anti-CD47 Antibody Revenue, (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Anti-CD47 Antibody Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibody
5.2.2 Polyclonal Antibody
5.3 Market Segment by Type
5.3.1 World Anti-CD47 Antibody Market Size by Type (2019-2024)
5.3.2 World Anti-CD47 Antibody Market Size by Type (2025-2030)
5.3.3 World Anti-CD47 Antibody Market Size Market Share by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Anti-CD47 Antibody Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Biotechnology
6.2.2 Medical
6.2.3 University
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Anti-CD47 Antibody Market Size by Application (2019-2024)
6.3.2 World Anti-CD47 Antibody Market Size by Application (2025-2030)
6.3.3 World Anti-CD47 Antibody Market Size by Application (2019-2030)
7 COMPANY PROFILES
7.1 BosterBio
7.1.1 BosterBio Details
7.1.2 BosterBio Major Business
7.1.3 BosterBio Anti-CD47 Antibody Product and Services
7.1.4 BosterBio Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 BosterBio Recent Developments/Updates
7.1.6 BosterBio Competitive Strengths & Weaknesses
7.2 Leinco Technologies
7.2.1 Leinco Technologies Details
7.2.2 Leinco Technologies Major Business
7.2.3 Leinco Technologies Anti-CD47 Antibody Product and Services
7.2.4 Leinco Technologies Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Leinco Technologies Recent Developments/Updates
7.2.6 Leinco Technologies Competitive Strengths & Weaknesses
7.3 Bioss
7.3.1 Bioss Details
7.3.2 Bioss Major Business
7.3.3 Bioss Anti-CD47 Antibody Product and Services
7.3.4 Bioss Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Bioss Recent Developments/Updates
7.3.6 Bioss Competitive Strengths & Weaknesses
7.4 Novus Biologicals
7.4.1 Novus Biologicals Details
7.4.2 Novus Biologicals Major Business
7.4.3 Novus Biologicals Anti-CD47 Antibody Product and Services
7.4.4 Novus Biologicals Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Novus Biologicals Recent Developments/Updates
7.4.6 Novus Biologicals Competitive Strengths & Weaknesses
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Details
7.5.2 Thermo Fisher Scientific Major Business
7.5.3 Thermo Fisher Scientific Anti-CD47 Antibody Product and Services
7.5.4 Thermo Fisher Scientific Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Thermo Fisher Scientific Recent Developments/Updates
7.5.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.6 Biorbyt
7.6.1 Biorbyt Details
7.6.2 Biorbyt Major Business
7.6.3 Biorbyt Anti-CD47 Antibody Product and Services
7.6.4 Biorbyt Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Biorbyt Recent Developments/Updates
7.6.6 Biorbyt Competitive Strengths & Weaknesses
7.7 Abbexa
7.7.1 Abbexa Details
7.7.2 Abbexa Major Business
7.7.3 Abbexa Anti-CD47 Antibody Product and Services
7.7.4 Abbexa Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Abbexa Recent Developments/Updates
7.7.6 Abbexa Competitive Strengths & Weaknesses
7.8 Bio X Cell
7.8.1 Bio X Cell Details
7.8.2 Bio X Cell Major Business
7.8.3 Bio X Cell Anti-CD47 Antibody Product and Services
7.8.4 Bio X Cell Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Bio X Cell Recent Developments/Updates
7.8.6 Bio X Cell Competitive Strengths & Weaknesses
7.9 GeneTex
7.9.1 GeneTex Details
7.9.2 GeneTex Major Business
7.9.3 GeneTex Anti-CD47 Antibody Product and Services
7.9.4 GeneTex Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 GeneTex Recent Developments/Updates
7.9.6 GeneTex Competitive Strengths & Weaknesses
7.10 R&D Systems
7.10.1 R&D Systems Details
7.10.2 R&D Systems Major Business
7.10.3 R&D Systems Anti-CD47 Antibody Product and Services
7.10.4 R&D Systems Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 R&D Systems Recent Developments/Updates
7.10.6 R&D Systems Competitive Strengths & Weaknesses
7.11 LSBio
7.11.1 LSBio Details
7.11.2 LSBio Major Business
7.11.3 LSBio Anti-CD47 Antibody Product and Services
7.11.4 LSBio Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 LSBio Recent Developments/Updates
7.11.6 LSBio Competitive Strengths & Weaknesses
7.12 MyBioSource
7.12.1 MyBioSource Details
7.12.2 MyBioSource Major Business
7.12.3 MyBioSource Anti-CD47 Antibody Product and Services
7.12.4 MyBioSource Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 MyBioSource Recent Developments/Updates
7.12.6 MyBioSource Competitive Strengths & Weaknesses
7.13 ProSci
7.13.1 ProSci Details
7.13.2 ProSci Major Business
7.13.3 ProSci Anti-CD47 Antibody Product and Services
7.13.4 ProSci Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 ProSci Recent Developments/Updates
7.13.6 ProSci Competitive Strengths & Weaknesses
7.14 antibodies-online
7.14.1 antibodies-online Details
7.14.2 antibodies-online Major Business
7.14.3 antibodies-online Anti-CD47 Antibody Product and Services
7.14.4 antibodies-online Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 antibodies-online Recent Developments/Updates
7.14.6 antibodies-online Competitive Strengths & Weaknesses
7.15 ABclonal Technology
7.15.1 ABclonal Technology Details
7.15.2 ABclonal Technology Major Business
7.15.3 ABclonal Technology Anti-CD47 Antibody Product and Services
7.15.4 ABclonal Technology Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 ABclonal Technology Recent Developments/Updates
7.15.6 ABclonal Technology Competitive Strengths & Weaknesses
7.16 Abnova Corporation
7.16.1 Abnova Corporation Details
7.16.2 Abnova Corporation Major Business
7.16.3 Abnova Corporation Anti-CD47 Antibody Product and Services
7.16.4 Abnova Corporation Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.16.5 Abnova Corporation Recent Developments/Updates
7.16.6 Abnova Corporation Competitive Strengths & Weaknesses
7.17 G Biosciences
7.17.1 G Biosciences Details
7.17.2 G Biosciences Major Business
7.17.3 G Biosciences Anti-CD47 Antibody Product and Services
7.17.4 G Biosciences Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.17.5 G Biosciences Recent Developments/Updates
7.17.6 G Biosciences Competitive Strengths & Weaknesses
7.18 BioLegend
7.18.1 BioLegend Details
7.18.2 BioLegend Major Business
7.18.3 BioLegend Anti-CD47 Antibody Product and Services
7.18.4 BioLegend Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.18.5 BioLegend Recent Developments/Updates
7.18.6 BioLegend Competitive Strengths & Weaknesses
7.19 Bio-Rad
7.19.1 Bio-Rad Details
7.19.2 Bio-Rad Major Business
7.19.3 Bio-Rad Anti-CD47 Antibody Product and Services
7.19.4 Bio-Rad Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.19.5 Bio-Rad Recent Developments/Updates
7.19.6 Bio-Rad Competitive Strengths & Weaknesses
7.20 Huabio
7.20.1 Huabio Details
7.20.2 Huabio Major Business
7.20.3 Huabio Anti-CD47 Antibody Product and Services
7.20.4 Huabio Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.20.5 Huabio Recent Developments/Updates
7.20.6 Huabio Competitive Strengths & Weaknesses
7.21 BPS Bioscience
7.21.1 BPS Bioscience Details
7.21.2 BPS Bioscience Major Business
7.21.3 BPS Bioscience Anti-CD47 Antibody Product and Services
7.21.4 BPS Bioscience Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.21.5 BPS Bioscience Recent Developments/Updates
7.21.6 BPS Bioscience Competitive Strengths & Weaknesses
7.22 OriGene Technologies
7.22.1 OriGene Technologies Details
7.22.2 OriGene Technologies Major Business
7.22.3 OriGene Technologies Anti-CD47 Antibody Product and Services
7.22.4 OriGene Technologies Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.22.5 OriGene Technologies Recent Developments/Updates
7.22.6 OriGene Technologies Competitive Strengths & Weaknesses
7.23 St John's Laboratory
7.23.1 St John's Laboratory Details
7.23.2 St John's Laboratory Major Business
7.23.3 St John's Laboratory Anti-CD47 Antibody Product and Services
7.23.4 St John's Laboratory Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.23.5 St John's Laboratory Recent Developments/Updates
7.23.6 St John's Laboratory Competitive Strengths & Weaknesses
7.24 Absolute Antibody
7.24.1 Absolute Antibody Details
7.24.2 Absolute Antibody Major Business
7.24.3 Absolute Antibody Anti-CD47 Antibody Product and Services
7.24.4 Absolute Antibody Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.24.5 Absolute Antibody Recent Developments/Updates
7.24.6 Absolute Antibody Competitive Strengths & Weaknesses
7.25 NSJ Bioreagents
7.25.1 NSJ Bioreagents Details
7.25.2 NSJ Bioreagents Major Business
7.25.3 NSJ Bioreagents Anti-CD47 Antibody Product and Services
7.25.4 NSJ Bioreagents Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.25.5 NSJ Bioreagents Recent Developments/Updates
7.25.6 NSJ Bioreagents Competitive Strengths & Weaknesses
7.26 Cell Signaling Technology
7.26.1 Cell Signaling Technology Details
7.26.2 Cell Signaling Technology Major Business
7.26.3 Cell Signaling Technology Anti-CD47 Antibody Product and Services
7.26.4 Cell Signaling Technology Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.26.5 Cell Signaling Technology Recent Developments/Updates
7.26.6 Cell Signaling Technology Competitive Strengths & Weaknesses
7.27 RayBiotech
7.27.1 RayBiotech Details
7.27.2 RayBiotech Major Business
7.27.3 RayBiotech Anti-CD47 Antibody Product and Services
7.27.4 RayBiotech Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.27.5 RayBiotech Recent Developments/Updates
7.27.6 RayBiotech Competitive Strengths & Weaknesses
7.28 Beijing Solarbio Science & Technology
7.28.1 Beijing Solarbio Science & Technology Details
7.28.2 Beijing Solarbio Science & Technology Major Business
7.28.3 Beijing Solarbio Science & Technology Anti-CD47 Antibody Product and Services
7.28.4 Beijing Solarbio Science & Technology Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.28.5 Beijing Solarbio Science & Technology Recent Developments/Updates
7.28.6 Beijing Solarbio Science & Technology Competitive Strengths & Weaknesses
7.29 Bethyl Laboratories
7.29.1 Bethyl Laboratories Details
7.29.2 Bethyl Laboratories Major Business
7.29.3 Bethyl Laboratories Anti-CD47 Antibody Product and Services
7.29.4 Bethyl Laboratories Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.29.5 Bethyl Laboratories Recent Developments/Updates
7.29.6 Bethyl Laboratories Competitive Strengths & Weaknesses
7.30 Abeomics
7.30.1 Abeomics Details
7.30.2 Abeomics Major Business
7.30.3 Abeomics Anti-CD47 Antibody Product and Services
7.30.4 Abeomics Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.30.5 Abeomics Recent Developments/Updates
7.30.6 Abeomics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Anti-CD47 Antibody Industry Chain
8.2 Anti-CD47 Antibody Upstream Analysis
8.3 Anti-CD47 Antibody Midstream Analysis
8.4 Anti-CD47 Antibody Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Anti-CD47 Antibody Introduction
1.2 World Anti-CD47 Antibody Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Anti-CD47 Antibody Total Market by Region (by Headquarter Location)
1.3.1 World Anti-CD47 Antibody Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Anti-CD47 Antibody Market Size (2019-2030)
1.3.3 China Anti-CD47 Antibody Market Size (2019-2030)
1.3.4 Europe Anti-CD47 Antibody Market Size (2019-2030)
1.3.5 Japan Anti-CD47 Antibody Market Size (2019-2030)
1.3.6 South Korea Anti-CD47 Antibody Market Size (2019-2030)
1.3.7 ASEAN Anti-CD47 Antibody Market Size (2019-2030)
1.3.8 India Anti-CD47 Antibody Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Anti-CD47 Antibody Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Anti-CD47 Antibody Major Market Trends
2 DEMAND SUMMARY
2.1 World Anti-CD47 Antibody Consumption Value (2019-2030)
2.2 World Anti-CD47 Antibody Consumption Value by Region
2.2.1 World Anti-CD47 Antibody Consumption Value by Region (2019-2024)
2.2.2 World Anti-CD47 Antibody Consumption Value Forecast by Region (2025-2030)
2.3 United States Anti-CD47 Antibody Consumption Value (2019-2030)
2.4 China Anti-CD47 Antibody Consumption Value (2019-2030)
2.5 Europe Anti-CD47 Antibody Consumption Value (2019-2030)
2.6 Japan Anti-CD47 Antibody Consumption Value (2019-2030)
2.7 South Korea Anti-CD47 Antibody Consumption Value (2019-2030)
2.8 ASEAN Anti-CD47 Antibody Consumption Value (2019-2030)
2.9 India Anti-CD47 Antibody Consumption Value (2019-2030)
3 WORLD ANTI-CD47 ANTIBODY COMPANIES COMPETITIVE ANALYSIS
3.1 World Anti-CD47 Antibody Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Anti-CD47 Antibody Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Anti-CD47 Antibody in 2023
3.2.3 Global Concentration Ratios (CR8) for Anti-CD47 Antibody in 2023
3.3 Anti-CD47 Antibody Company Evaluation Quadrant
3.4 Anti-CD47 Antibody Market: Overall Company Footprint Analysis
3.4.1 Anti-CD47 Antibody Market: Region Footprint
3.4.2 Anti-CD47 Antibody Market: Company Product Type Footprint
3.4.3 Anti-CD47 Antibody Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Anti-CD47 Antibody Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Anti-CD47 Antibody Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Anti-CD47 Antibody Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Anti-CD47 Antibody Consumption Value Comparison
4.2.1 United States VS China: Anti-CD47 Antibody Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Anti-CD47 Antibody Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Anti-CD47 Antibody Companies and Market Share, 2019-2024
4.3.1 United States Based Anti-CD47 Antibody Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Anti-CD47 Antibody Revenue, (2019-2024)
4.4 China Based Companies Anti-CD47 Antibody Revenue and Market Share, 2019-2024
4.4.1 China Based Anti-CD47 Antibody Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Anti-CD47 Antibody Revenue, (2019-2024)
4.5 Rest of World Based Anti-CD47 Antibody Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Anti-CD47 Antibody Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Anti-CD47 Antibody Revenue, (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Anti-CD47 Antibody Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibody
5.2.2 Polyclonal Antibody
5.3 Market Segment by Type
5.3.1 World Anti-CD47 Antibody Market Size by Type (2019-2024)
5.3.2 World Anti-CD47 Antibody Market Size by Type (2025-2030)
5.3.3 World Anti-CD47 Antibody Market Size Market Share by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Anti-CD47 Antibody Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Biotechnology
6.2.2 Medical
6.2.3 University
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Anti-CD47 Antibody Market Size by Application (2019-2024)
6.3.2 World Anti-CD47 Antibody Market Size by Application (2025-2030)
6.3.3 World Anti-CD47 Antibody Market Size by Application (2019-2030)
7 COMPANY PROFILES
7.1 BosterBio
7.1.1 BosterBio Details
7.1.2 BosterBio Major Business
7.1.3 BosterBio Anti-CD47 Antibody Product and Services
7.1.4 BosterBio Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 BosterBio Recent Developments/Updates
7.1.6 BosterBio Competitive Strengths & Weaknesses
7.2 Leinco Technologies
7.2.1 Leinco Technologies Details
7.2.2 Leinco Technologies Major Business
7.2.3 Leinco Technologies Anti-CD47 Antibody Product and Services
7.2.4 Leinco Technologies Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Leinco Technologies Recent Developments/Updates
7.2.6 Leinco Technologies Competitive Strengths & Weaknesses
7.3 Bioss
7.3.1 Bioss Details
7.3.2 Bioss Major Business
7.3.3 Bioss Anti-CD47 Antibody Product and Services
7.3.4 Bioss Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Bioss Recent Developments/Updates
7.3.6 Bioss Competitive Strengths & Weaknesses
7.4 Novus Biologicals
7.4.1 Novus Biologicals Details
7.4.2 Novus Biologicals Major Business
7.4.3 Novus Biologicals Anti-CD47 Antibody Product and Services
7.4.4 Novus Biologicals Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Novus Biologicals Recent Developments/Updates
7.4.6 Novus Biologicals Competitive Strengths & Weaknesses
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Details
7.5.2 Thermo Fisher Scientific Major Business
7.5.3 Thermo Fisher Scientific Anti-CD47 Antibody Product and Services
7.5.4 Thermo Fisher Scientific Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Thermo Fisher Scientific Recent Developments/Updates
7.5.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.6 Biorbyt
7.6.1 Biorbyt Details
7.6.2 Biorbyt Major Business
7.6.3 Biorbyt Anti-CD47 Antibody Product and Services
7.6.4 Biorbyt Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Biorbyt Recent Developments/Updates
7.6.6 Biorbyt Competitive Strengths & Weaknesses
7.7 Abbexa
7.7.1 Abbexa Details
7.7.2 Abbexa Major Business
7.7.3 Abbexa Anti-CD47 Antibody Product and Services
7.7.4 Abbexa Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Abbexa Recent Developments/Updates
7.7.6 Abbexa Competitive Strengths & Weaknesses
7.8 Bio X Cell
7.8.1 Bio X Cell Details
7.8.2 Bio X Cell Major Business
7.8.3 Bio X Cell Anti-CD47 Antibody Product and Services
7.8.4 Bio X Cell Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Bio X Cell Recent Developments/Updates
7.8.6 Bio X Cell Competitive Strengths & Weaknesses
7.9 GeneTex
7.9.1 GeneTex Details
7.9.2 GeneTex Major Business
7.9.3 GeneTex Anti-CD47 Antibody Product and Services
7.9.4 GeneTex Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 GeneTex Recent Developments/Updates
7.9.6 GeneTex Competitive Strengths & Weaknesses
7.10 R&D Systems
7.10.1 R&D Systems Details
7.10.2 R&D Systems Major Business
7.10.3 R&D Systems Anti-CD47 Antibody Product and Services
7.10.4 R&D Systems Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 R&D Systems Recent Developments/Updates
7.10.6 R&D Systems Competitive Strengths & Weaknesses
7.11 LSBio
7.11.1 LSBio Details
7.11.2 LSBio Major Business
7.11.3 LSBio Anti-CD47 Antibody Product and Services
7.11.4 LSBio Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 LSBio Recent Developments/Updates
7.11.6 LSBio Competitive Strengths & Weaknesses
7.12 MyBioSource
7.12.1 MyBioSource Details
7.12.2 MyBioSource Major Business
7.12.3 MyBioSource Anti-CD47 Antibody Product and Services
7.12.4 MyBioSource Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 MyBioSource Recent Developments/Updates
7.12.6 MyBioSource Competitive Strengths & Weaknesses
7.13 ProSci
7.13.1 ProSci Details
7.13.2 ProSci Major Business
7.13.3 ProSci Anti-CD47 Antibody Product and Services
7.13.4 ProSci Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 ProSci Recent Developments/Updates
7.13.6 ProSci Competitive Strengths & Weaknesses
7.14 antibodies-online
7.14.1 antibodies-online Details
7.14.2 antibodies-online Major Business
7.14.3 antibodies-online Anti-CD47 Antibody Product and Services
7.14.4 antibodies-online Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 antibodies-online Recent Developments/Updates
7.14.6 antibodies-online Competitive Strengths & Weaknesses
7.15 ABclonal Technology
7.15.1 ABclonal Technology Details
7.15.2 ABclonal Technology Major Business
7.15.3 ABclonal Technology Anti-CD47 Antibody Product and Services
7.15.4 ABclonal Technology Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 ABclonal Technology Recent Developments/Updates
7.15.6 ABclonal Technology Competitive Strengths & Weaknesses
7.16 Abnova Corporation
7.16.1 Abnova Corporation Details
7.16.2 Abnova Corporation Major Business
7.16.3 Abnova Corporation Anti-CD47 Antibody Product and Services
7.16.4 Abnova Corporation Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.16.5 Abnova Corporation Recent Developments/Updates
7.16.6 Abnova Corporation Competitive Strengths & Weaknesses
7.17 G Biosciences
7.17.1 G Biosciences Details
7.17.2 G Biosciences Major Business
7.17.3 G Biosciences Anti-CD47 Antibody Product and Services
7.17.4 G Biosciences Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.17.5 G Biosciences Recent Developments/Updates
7.17.6 G Biosciences Competitive Strengths & Weaknesses
7.18 BioLegend
7.18.1 BioLegend Details
7.18.2 BioLegend Major Business
7.18.3 BioLegend Anti-CD47 Antibody Product and Services
7.18.4 BioLegend Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.18.5 BioLegend Recent Developments/Updates
7.18.6 BioLegend Competitive Strengths & Weaknesses
7.19 Bio-Rad
7.19.1 Bio-Rad Details
7.19.2 Bio-Rad Major Business
7.19.3 Bio-Rad Anti-CD47 Antibody Product and Services
7.19.4 Bio-Rad Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.19.5 Bio-Rad Recent Developments/Updates
7.19.6 Bio-Rad Competitive Strengths & Weaknesses
7.20 Huabio
7.20.1 Huabio Details
7.20.2 Huabio Major Business
7.20.3 Huabio Anti-CD47 Antibody Product and Services
7.20.4 Huabio Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.20.5 Huabio Recent Developments/Updates
7.20.6 Huabio Competitive Strengths & Weaknesses
7.21 BPS Bioscience
7.21.1 BPS Bioscience Details
7.21.2 BPS Bioscience Major Business
7.21.3 BPS Bioscience Anti-CD47 Antibody Product and Services
7.21.4 BPS Bioscience Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.21.5 BPS Bioscience Recent Developments/Updates
7.21.6 BPS Bioscience Competitive Strengths & Weaknesses
7.22 OriGene Technologies
7.22.1 OriGene Technologies Details
7.22.2 OriGene Technologies Major Business
7.22.3 OriGene Technologies Anti-CD47 Antibody Product and Services
7.22.4 OriGene Technologies Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.22.5 OriGene Technologies Recent Developments/Updates
7.22.6 OriGene Technologies Competitive Strengths & Weaknesses
7.23 St John's Laboratory
7.23.1 St John's Laboratory Details
7.23.2 St John's Laboratory Major Business
7.23.3 St John's Laboratory Anti-CD47 Antibody Product and Services
7.23.4 St John's Laboratory Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.23.5 St John's Laboratory Recent Developments/Updates
7.23.6 St John's Laboratory Competitive Strengths & Weaknesses
7.24 Absolute Antibody
7.24.1 Absolute Antibody Details
7.24.2 Absolute Antibody Major Business
7.24.3 Absolute Antibody Anti-CD47 Antibody Product and Services
7.24.4 Absolute Antibody Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.24.5 Absolute Antibody Recent Developments/Updates
7.24.6 Absolute Antibody Competitive Strengths & Weaknesses
7.25 NSJ Bioreagents
7.25.1 NSJ Bioreagents Details
7.25.2 NSJ Bioreagents Major Business
7.25.3 NSJ Bioreagents Anti-CD47 Antibody Product and Services
7.25.4 NSJ Bioreagents Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.25.5 NSJ Bioreagents Recent Developments/Updates
7.25.6 NSJ Bioreagents Competitive Strengths & Weaknesses
7.26 Cell Signaling Technology
7.26.1 Cell Signaling Technology Details
7.26.2 Cell Signaling Technology Major Business
7.26.3 Cell Signaling Technology Anti-CD47 Antibody Product and Services
7.26.4 Cell Signaling Technology Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.26.5 Cell Signaling Technology Recent Developments/Updates
7.26.6 Cell Signaling Technology Competitive Strengths & Weaknesses
7.27 RayBiotech
7.27.1 RayBiotech Details
7.27.2 RayBiotech Major Business
7.27.3 RayBiotech Anti-CD47 Antibody Product and Services
7.27.4 RayBiotech Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.27.5 RayBiotech Recent Developments/Updates
7.27.6 RayBiotech Competitive Strengths & Weaknesses
7.28 Beijing Solarbio Science & Technology
7.28.1 Beijing Solarbio Science & Technology Details
7.28.2 Beijing Solarbio Science & Technology Major Business
7.28.3 Beijing Solarbio Science & Technology Anti-CD47 Antibody Product and Services
7.28.4 Beijing Solarbio Science & Technology Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.28.5 Beijing Solarbio Science & Technology Recent Developments/Updates
7.28.6 Beijing Solarbio Science & Technology Competitive Strengths & Weaknesses
7.29 Bethyl Laboratories
7.29.1 Bethyl Laboratories Details
7.29.2 Bethyl Laboratories Major Business
7.29.3 Bethyl Laboratories Anti-CD47 Antibody Product and Services
7.29.4 Bethyl Laboratories Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.29.5 Bethyl Laboratories Recent Developments/Updates
7.29.6 Bethyl Laboratories Competitive Strengths & Weaknesses
7.30 Abeomics
7.30.1 Abeomics Details
7.30.2 Abeomics Major Business
7.30.3 Abeomics Anti-CD47 Antibody Product and Services
7.30.4 Abeomics Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
7.30.5 Abeomics Recent Developments/Updates
7.30.6 Abeomics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Anti-CD47 Antibody Industry Chain
8.2 Anti-CD47 Antibody Upstream Analysis
8.3 Anti-CD47 Antibody Midstream Analysis
8.4 Anti-CD47 Antibody Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
.
Table 1. World Anti-CD47 Antibody Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Anti-CD47 Antibody Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Anti-CD47 Antibody Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Anti-CD47 Antibody Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Anti-CD47 Antibody Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Anti-CD47 Antibody Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Anti-CD47 Antibody Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Anti-CD47 Antibody Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Anti-CD47 Antibody Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Anti-CD47 Antibody Players in 2023
Table 12. World Anti-CD47 Antibody Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Anti-CD47 Antibody Company Evaluation Quadrant
Table 14. Head Office of Key Anti-CD47 Antibody Player
Table 15. Anti-CD47 Antibody Market: Company Product Type Footprint
Table 16. Anti-CD47 Antibody Market: Company Product Application Footprint
Table 17. Anti-CD47 Antibody Mergers & Acquisitions Activity
Table 18. United States VS China Anti-CD47 Antibody Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Anti-CD47 Antibody Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Anti-CD47 Antibody Companies, Headquarters (States, Country)
Table 21. United States Based Companies Anti-CD47 Antibody Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Anti-CD47 Antibody Revenue Market Share (2019-2024)
Table 23. China Based Anti-CD47 Antibody Companies, Headquarters (Province, Country)
Table 24. China Based Companies Anti-CD47 Antibody Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Anti-CD47 Antibody Revenue Market Share (2019-2024)
Table 26. Rest of World Based Anti-CD47 Antibody Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Anti-CD47 Antibody Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Anti-CD47 Antibody Revenue Market Share (2019-2024)
Table 29. World Anti-CD47 Antibody Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Anti-CD47 Antibody Market Size by Type (2019-2024) & (USD Million)
Table 31. World Anti-CD47 Antibody Market Size by Type (2025-2030) & (USD Million)
Table 32. World Anti-CD47 Antibody Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Anti-CD47 Antibody Market Size by Application (2019-2024) & (USD Million)
Table 34. World Anti-CD47 Antibody Market Size by Application (2025-2030) & (USD Million)
Table 35. BosterBio Basic Information, Area Served and Competitors
Table 36. BosterBio Major Business
Table 37. BosterBio Anti-CD47 Antibody Product and Services
Table 38. BosterBio Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. BosterBio Recent Developments/Updates
Table 40. BosterBio Competitive Strengths & Weaknesses
Table 41. Leinco Technologies Basic Information, Area Served and Competitors
Table 42. Leinco Technologies Major Business
Table 43. Leinco Technologies Anti-CD47 Antibody Product and Services
Table 44. Leinco Technologies Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Leinco Technologies Recent Developments/Updates
Table 46. Leinco Technologies Competitive Strengths & Weaknesses
Table 47. Bioss Basic Information, Area Served and Competitors
Table 48. Bioss Major Business
Table 49. Bioss Anti-CD47 Antibody Product and Services
Table 50. Bioss Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Bioss Recent Developments/Updates
Table 52. Bioss Competitive Strengths & Weaknesses
Table 53. Novus Biologicals Basic Information, Area Served and Competitors
Table 54. Novus Biologicals Major Business
Table 55. Novus Biologicals Anti-CD47 Antibody Product and Services
Table 56. Novus Biologicals Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Novus Biologicals Recent Developments/Updates
Table 58. Novus Biologicals Competitive Strengths & Weaknesses
Table 59. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 60. Thermo Fisher Scientific Major Business
Table 61. Thermo Fisher Scientific Anti-CD47 Antibody Product and Services
Table 62. Thermo Fisher Scientific Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Thermo Fisher Scientific Recent Developments/Updates
Table 64. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 65. Biorbyt Basic Information, Area Served and Competitors
Table 66. Biorbyt Major Business
Table 67. Biorbyt Anti-CD47 Antibody Product and Services
Table 68. Biorbyt Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Biorbyt Recent Developments/Updates
Table 70. Biorbyt Competitive Strengths & Weaknesses
Table 71. Abbexa Basic Information, Area Served and Competitors
Table 72. Abbexa Major Business
Table 73. Abbexa Anti-CD47 Antibody Product and Services
Table 74. Abbexa Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Abbexa Recent Developments/Updates
Table 76. Abbexa Competitive Strengths & Weaknesses
Table 77. Bio X Cell Basic Information, Area Served and Competitors
Table 78. Bio X Cell Major Business
Table 79. Bio X Cell Anti-CD47 Antibody Product and Services
Table 80. Bio X Cell Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Bio X Cell Recent Developments/Updates
Table 82. Bio X Cell Competitive Strengths & Weaknesses
Table 83. GeneTex Basic Information, Area Served and Competitors
Table 84. GeneTex Major Business
Table 85. GeneTex Anti-CD47 Antibody Product and Services
Table 86. GeneTex Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. GeneTex Recent Developments/Updates
Table 88. GeneTex Competitive Strengths & Weaknesses
Table 89. R&D Systems Basic Information, Area Served and Competitors
Table 90. R&D Systems Major Business
Table 91. R&D Systems Anti-CD47 Antibody Product and Services
Table 92. R&D Systems Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. R&D Systems Recent Developments/Updates
Table 94. R&D Systems Competitive Strengths & Weaknesses
Table 95. LSBio Basic Information, Area Served and Competitors
Table 96. LSBio Major Business
Table 97. LSBio Anti-CD47 Antibody Product and Services
Table 98. LSBio Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. LSBio Recent Developments/Updates
Table 100. LSBio Competitive Strengths & Weaknesses
Table 101. MyBioSource Basic Information, Area Served and Competitors
Table 102. MyBioSource Major Business
Table 103. MyBioSource Anti-CD47 Antibody Product and Services
Table 104. MyBioSource Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. MyBioSource Recent Developments/Updates
Table 106. MyBioSource Competitive Strengths & Weaknesses
Table 107. ProSci Basic Information, Area Served and Competitors
Table 108. ProSci Major Business
Table 109. ProSci Anti-CD47 Antibody Product and Services
Table 110. ProSci Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. ProSci Recent Developments/Updates
Table 112. ProSci Competitive Strengths & Weaknesses
Table 113. antibodies-online Basic Information, Area Served and Competitors
Table 114. antibodies-online Major Business
Table 115. antibodies-online Anti-CD47 Antibody Product and Services
Table 116. antibodies-online Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. antibodies-online Recent Developments/Updates
Table 118. antibodies-online Competitive Strengths & Weaknesses
Table 119. ABclonal Technology Basic Information, Area Served and Competitors
Table 120. ABclonal Technology Major Business
Table 121. ABclonal Technology Anti-CD47 Antibody Product and Services
Table 122. ABclonal Technology Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 123. ABclonal Technology Recent Developments/Updates
Table 124. ABclonal Technology Competitive Strengths & Weaknesses
Table 125. Abnova Corporation Basic Information, Area Served and Competitors
Table 126. Abnova Corporation Major Business
Table 127. Abnova Corporation Anti-CD47 Antibody Product and Services
Table 128. Abnova Corporation Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 129. Abnova Corporation Recent Developments/Updates
Table 130. Abnova Corporation Competitive Strengths & Weaknesses
Table 131. G Biosciences Basic Information, Area Served and Competitors
Table 132. G Biosciences Major Business
Table 133. G Biosciences Anti-CD47 Antibody Product and Services
Table 134. G Biosciences Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 135. G Biosciences Recent Developments/Updates
Table 136. G Biosciences Competitive Strengths & Weaknesses
Table 137. BioLegend Basic Information, Area Served and Competitors
Table 138. BioLegend Major Business
Table 139. BioLegend Anti-CD47 Antibody Product and Services
Table 140. BioLegend Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 141. BioLegend Recent Developments/Updates
Table 142. BioLegend Competitive Strengths & Weaknesses
Table 143. Bio-Rad Basic Information, Area Served and Competitors
Table 144. Bio-Rad Major Business
Table 145. Bio-Rad Anti-CD47 Antibody Product and Services
Table 146. Bio-Rad Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 147. Bio-Rad Recent Developments/Updates
Table 148. Bio-Rad Competitive Strengths & Weaknesses
Table 149. Huabio Basic Information, Area Served and Competitors
Table 150. Huabio Major Business
Table 151. Huabio Anti-CD47 Antibody Product and Services
Table 152. Huabio Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 153. Huabio Recent Developments/Updates
Table 154. Huabio Competitive Strengths & Weaknesses
Table 155. BPS Bioscience Basic Information, Area Served and Competitors
Table 156. BPS Bioscience Major Business
Table 157. BPS Bioscience Anti-CD47 Antibody Product and Services
Table 158. BPS Bioscience Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 159. BPS Bioscience Recent Developments/Updates
Table 160. BPS Bioscience Competitive Strengths & Weaknesses
Table 161. OriGene Technologies Basic Information, Area Served and Competitors
Table 162. OriGene Technologies Major Business
Table 163. OriGene Technologies Anti-CD47 Antibody Product and Services
Table 164. OriGene Technologies Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 165. OriGene Technologies Recent Developments/Updates
Table 166. OriGene Technologies Competitive Strengths & Weaknesses
Table 167. St John's Laboratory Basic Information, Area Served and Competitors
Table 168. St John's Laboratory Major Business
Table 169. St John's Laboratory Anti-CD47 Antibody Product and Services
Table 170. St John's Laboratory Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 171. St John's Laboratory Recent Developments/Updates
Table 172. St John's Laboratory Competitive Strengths & Weaknesses
Table 173. Absolute Antibody Basic Information, Area Served and Competitors
Table 174. Absolute Antibody Major Business
Table 175. Absolute Antibody Anti-CD47 Antibody Product and Services
Table 176. Absolute Antibody Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 177. Absolute Antibody Recent Developments/Updates
Table 178. Absolute Antibody Competitive Strengths & Weaknesses
Table 179. NSJ Bioreagents Basic Information, Area Served and Competitors
Table 180. NSJ Bioreagents Major Business
Table 181. NSJ Bioreagents Anti-CD47 Antibody Product and Services
Table 182. NSJ Bioreagents Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 183. NSJ Bioreagents Recent Developments/Updates
Table 184. NSJ Bioreagents Competitive Strengths & Weaknesses
Table 185. Cell Signaling Technology Basic Information, Area Served and Competitors
Table 186. Cell Signaling Technology Major Business
Table 187. Cell Signaling Technology Anti-CD47 Antibody Product and Services
Table 188. Cell Signaling Technology Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 189. Cell Signaling Technology Recent Developments/Updates
Table 190. Cell Signaling Technology Competitive Strengths & Weaknesses
Table 191. RayBiotech Basic Information, Area Served and Competitors
Table 192. RayBiotech Major Business
Table 193. RayBiotech Anti-CD47 Antibody Product and Services
Table 194. RayBiotech Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 195. RayBiotech Recent Developments/Updates
Table 196. RayBiotech Competitive Strengths & Weaknesses
Table 197. Beijing Solarbio Science & Technology Basic Information, Area Served and Competitors
Table 198. Beijing Solarbio Science & Technology Major Business
Table 199. Beijing Solarbio Science & Technology Anti-CD47 Antibody Product and Services
Table 200. Beijing Solarbio Science & Technology Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 201. Beijing Solarbio Science & Technology Recent Developments/Updates
Table 202. Beijing Solarbio Science & Technology Competitive Strengths & Weaknesses
Table 203. Bethyl Laboratories Basic Information, Area Served and Competitors
Table 204. Bethyl LaboratoriesMajor Business
Table 205. Bethyl Laboratories Anti-CD47 Antibody Product and Services
Table 206. Bethyl Laboratories Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 207. Bethyl Laboratories Recent Developments/Updates
Table 208. Abeomics Basic Information, Area Served and Competitors
Table 209. Abeomics Major Business
Table 210. Abeomics Anti-CD47 Antibody Product and Services
Table 211. Abeomics Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 212. Global Key Players of Anti-CD47 Antibody Upstream (Raw Materials)
Table 213. Anti-CD47 Antibody Typical Customers
LIST OF FIGURE
.
Figure 1. Anti-CD47 Antibody Picture
Figure 2. World Anti-CD47 Antibody Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Anti-CD47 Antibody Total Market Size (2019-2030) & (USD Million)
Figure 4. World Anti-CD47 Antibody Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Anti-CD47 Antibody Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Anti-CD47 Antibody Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Anti-CD47 Antibody Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Anti-CD47 Antibody Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Anti-CD47 Antibody Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Anti-CD47 Antibody Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Anti-CD47 Antibody Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Anti-CD47 Antibody Revenue (2019-2030) & (USD Million)
Figure 13. Anti-CD47 Antibody Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 16. World Anti-CD47 Antibody Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 18. China Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 23. India Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Anti-CD47 Antibody by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Anti-CD47 Antibody Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Anti-CD47 Antibody Markets in 2023
Figure 27. United States VS China: Anti-CD47 Antibody Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Anti-CD47 Antibody Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Anti-CD47 Antibody Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Anti-CD47 Antibody Market Size Market Share by Type in 2023
Figure 31. Monoclonal Antibody
Figure 32. Polyclonal Antibody
Figure 33. World Anti-CD47 Antibody Market Size Market Share by Type (2019-2030)
Figure 34. World Anti-CD47 Antibody Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World Anti-CD47 Antibody Market Size Market Share by Application in 2023
Figure 36. Biotechnology
Figure 37. Medical
Figure 38. University
Figure 39. Others
Figure 40. Anti-CD47 Antibody Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
.
Table 1. World Anti-CD47 Antibody Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Anti-CD47 Antibody Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Anti-CD47 Antibody Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Anti-CD47 Antibody Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Anti-CD47 Antibody Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Anti-CD47 Antibody Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Anti-CD47 Antibody Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Anti-CD47 Antibody Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Anti-CD47 Antibody Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Anti-CD47 Antibody Players in 2023
Table 12. World Anti-CD47 Antibody Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Anti-CD47 Antibody Company Evaluation Quadrant
Table 14. Head Office of Key Anti-CD47 Antibody Player
Table 15. Anti-CD47 Antibody Market: Company Product Type Footprint
Table 16. Anti-CD47 Antibody Market: Company Product Application Footprint
Table 17. Anti-CD47 Antibody Mergers & Acquisitions Activity
Table 18. United States VS China Anti-CD47 Antibody Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Anti-CD47 Antibody Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Anti-CD47 Antibody Companies, Headquarters (States, Country)
Table 21. United States Based Companies Anti-CD47 Antibody Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Anti-CD47 Antibody Revenue Market Share (2019-2024)
Table 23. China Based Anti-CD47 Antibody Companies, Headquarters (Province, Country)
Table 24. China Based Companies Anti-CD47 Antibody Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Anti-CD47 Antibody Revenue Market Share (2019-2024)
Table 26. Rest of World Based Anti-CD47 Antibody Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Anti-CD47 Antibody Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Anti-CD47 Antibody Revenue Market Share (2019-2024)
Table 29. World Anti-CD47 Antibody Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Anti-CD47 Antibody Market Size by Type (2019-2024) & (USD Million)
Table 31. World Anti-CD47 Antibody Market Size by Type (2025-2030) & (USD Million)
Table 32. World Anti-CD47 Antibody Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Anti-CD47 Antibody Market Size by Application (2019-2024) & (USD Million)
Table 34. World Anti-CD47 Antibody Market Size by Application (2025-2030) & (USD Million)
Table 35. BosterBio Basic Information, Area Served and Competitors
Table 36. BosterBio Major Business
Table 37. BosterBio Anti-CD47 Antibody Product and Services
Table 38. BosterBio Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. BosterBio Recent Developments/Updates
Table 40. BosterBio Competitive Strengths & Weaknesses
Table 41. Leinco Technologies Basic Information, Area Served and Competitors
Table 42. Leinco Technologies Major Business
Table 43. Leinco Technologies Anti-CD47 Antibody Product and Services
Table 44. Leinco Technologies Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Leinco Technologies Recent Developments/Updates
Table 46. Leinco Technologies Competitive Strengths & Weaknesses
Table 47. Bioss Basic Information, Area Served and Competitors
Table 48. Bioss Major Business
Table 49. Bioss Anti-CD47 Antibody Product and Services
Table 50. Bioss Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Bioss Recent Developments/Updates
Table 52. Bioss Competitive Strengths & Weaknesses
Table 53. Novus Biologicals Basic Information, Area Served and Competitors
Table 54. Novus Biologicals Major Business
Table 55. Novus Biologicals Anti-CD47 Antibody Product and Services
Table 56. Novus Biologicals Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Novus Biologicals Recent Developments/Updates
Table 58. Novus Biologicals Competitive Strengths & Weaknesses
Table 59. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 60. Thermo Fisher Scientific Major Business
Table 61. Thermo Fisher Scientific Anti-CD47 Antibody Product and Services
Table 62. Thermo Fisher Scientific Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Thermo Fisher Scientific Recent Developments/Updates
Table 64. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 65. Biorbyt Basic Information, Area Served and Competitors
Table 66. Biorbyt Major Business
Table 67. Biorbyt Anti-CD47 Antibody Product and Services
Table 68. Biorbyt Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Biorbyt Recent Developments/Updates
Table 70. Biorbyt Competitive Strengths & Weaknesses
Table 71. Abbexa Basic Information, Area Served and Competitors
Table 72. Abbexa Major Business
Table 73. Abbexa Anti-CD47 Antibody Product and Services
Table 74. Abbexa Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Abbexa Recent Developments/Updates
Table 76. Abbexa Competitive Strengths & Weaknesses
Table 77. Bio X Cell Basic Information, Area Served and Competitors
Table 78. Bio X Cell Major Business
Table 79. Bio X Cell Anti-CD47 Antibody Product and Services
Table 80. Bio X Cell Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Bio X Cell Recent Developments/Updates
Table 82. Bio X Cell Competitive Strengths & Weaknesses
Table 83. GeneTex Basic Information, Area Served and Competitors
Table 84. GeneTex Major Business
Table 85. GeneTex Anti-CD47 Antibody Product and Services
Table 86. GeneTex Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. GeneTex Recent Developments/Updates
Table 88. GeneTex Competitive Strengths & Weaknesses
Table 89. R&D Systems Basic Information, Area Served and Competitors
Table 90. R&D Systems Major Business
Table 91. R&D Systems Anti-CD47 Antibody Product and Services
Table 92. R&D Systems Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. R&D Systems Recent Developments/Updates
Table 94. R&D Systems Competitive Strengths & Weaknesses
Table 95. LSBio Basic Information, Area Served and Competitors
Table 96. LSBio Major Business
Table 97. LSBio Anti-CD47 Antibody Product and Services
Table 98. LSBio Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. LSBio Recent Developments/Updates
Table 100. LSBio Competitive Strengths & Weaknesses
Table 101. MyBioSource Basic Information, Area Served and Competitors
Table 102. MyBioSource Major Business
Table 103. MyBioSource Anti-CD47 Antibody Product and Services
Table 104. MyBioSource Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. MyBioSource Recent Developments/Updates
Table 106. MyBioSource Competitive Strengths & Weaknesses
Table 107. ProSci Basic Information, Area Served and Competitors
Table 108. ProSci Major Business
Table 109. ProSci Anti-CD47 Antibody Product and Services
Table 110. ProSci Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. ProSci Recent Developments/Updates
Table 112. ProSci Competitive Strengths & Weaknesses
Table 113. antibodies-online Basic Information, Area Served and Competitors
Table 114. antibodies-online Major Business
Table 115. antibodies-online Anti-CD47 Antibody Product and Services
Table 116. antibodies-online Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. antibodies-online Recent Developments/Updates
Table 118. antibodies-online Competitive Strengths & Weaknesses
Table 119. ABclonal Technology Basic Information, Area Served and Competitors
Table 120. ABclonal Technology Major Business
Table 121. ABclonal Technology Anti-CD47 Antibody Product and Services
Table 122. ABclonal Technology Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 123. ABclonal Technology Recent Developments/Updates
Table 124. ABclonal Technology Competitive Strengths & Weaknesses
Table 125. Abnova Corporation Basic Information, Area Served and Competitors
Table 126. Abnova Corporation Major Business
Table 127. Abnova Corporation Anti-CD47 Antibody Product and Services
Table 128. Abnova Corporation Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 129. Abnova Corporation Recent Developments/Updates
Table 130. Abnova Corporation Competitive Strengths & Weaknesses
Table 131. G Biosciences Basic Information, Area Served and Competitors
Table 132. G Biosciences Major Business
Table 133. G Biosciences Anti-CD47 Antibody Product and Services
Table 134. G Biosciences Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 135. G Biosciences Recent Developments/Updates
Table 136. G Biosciences Competitive Strengths & Weaknesses
Table 137. BioLegend Basic Information, Area Served and Competitors
Table 138. BioLegend Major Business
Table 139. BioLegend Anti-CD47 Antibody Product and Services
Table 140. BioLegend Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 141. BioLegend Recent Developments/Updates
Table 142. BioLegend Competitive Strengths & Weaknesses
Table 143. Bio-Rad Basic Information, Area Served and Competitors
Table 144. Bio-Rad Major Business
Table 145. Bio-Rad Anti-CD47 Antibody Product and Services
Table 146. Bio-Rad Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 147. Bio-Rad Recent Developments/Updates
Table 148. Bio-Rad Competitive Strengths & Weaknesses
Table 149. Huabio Basic Information, Area Served and Competitors
Table 150. Huabio Major Business
Table 151. Huabio Anti-CD47 Antibody Product and Services
Table 152. Huabio Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 153. Huabio Recent Developments/Updates
Table 154. Huabio Competitive Strengths & Weaknesses
Table 155. BPS Bioscience Basic Information, Area Served and Competitors
Table 156. BPS Bioscience Major Business
Table 157. BPS Bioscience Anti-CD47 Antibody Product and Services
Table 158. BPS Bioscience Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 159. BPS Bioscience Recent Developments/Updates
Table 160. BPS Bioscience Competitive Strengths & Weaknesses
Table 161. OriGene Technologies Basic Information, Area Served and Competitors
Table 162. OriGene Technologies Major Business
Table 163. OriGene Technologies Anti-CD47 Antibody Product and Services
Table 164. OriGene Technologies Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 165. OriGene Technologies Recent Developments/Updates
Table 166. OriGene Technologies Competitive Strengths & Weaknesses
Table 167. St John's Laboratory Basic Information, Area Served and Competitors
Table 168. St John's Laboratory Major Business
Table 169. St John's Laboratory Anti-CD47 Antibody Product and Services
Table 170. St John's Laboratory Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 171. St John's Laboratory Recent Developments/Updates
Table 172. St John's Laboratory Competitive Strengths & Weaknesses
Table 173. Absolute Antibody Basic Information, Area Served and Competitors
Table 174. Absolute Antibody Major Business
Table 175. Absolute Antibody Anti-CD47 Antibody Product and Services
Table 176. Absolute Antibody Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 177. Absolute Antibody Recent Developments/Updates
Table 178. Absolute Antibody Competitive Strengths & Weaknesses
Table 179. NSJ Bioreagents Basic Information, Area Served and Competitors
Table 180. NSJ Bioreagents Major Business
Table 181. NSJ Bioreagents Anti-CD47 Antibody Product and Services
Table 182. NSJ Bioreagents Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 183. NSJ Bioreagents Recent Developments/Updates
Table 184. NSJ Bioreagents Competitive Strengths & Weaknesses
Table 185. Cell Signaling Technology Basic Information, Area Served and Competitors
Table 186. Cell Signaling Technology Major Business
Table 187. Cell Signaling Technology Anti-CD47 Antibody Product and Services
Table 188. Cell Signaling Technology Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 189. Cell Signaling Technology Recent Developments/Updates
Table 190. Cell Signaling Technology Competitive Strengths & Weaknesses
Table 191. RayBiotech Basic Information, Area Served and Competitors
Table 192. RayBiotech Major Business
Table 193. RayBiotech Anti-CD47 Antibody Product and Services
Table 194. RayBiotech Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 195. RayBiotech Recent Developments/Updates
Table 196. RayBiotech Competitive Strengths & Weaknesses
Table 197. Beijing Solarbio Science & Technology Basic Information, Area Served and Competitors
Table 198. Beijing Solarbio Science & Technology Major Business
Table 199. Beijing Solarbio Science & Technology Anti-CD47 Antibody Product and Services
Table 200. Beijing Solarbio Science & Technology Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 201. Beijing Solarbio Science & Technology Recent Developments/Updates
Table 202. Beijing Solarbio Science & Technology Competitive Strengths & Weaknesses
Table 203. Bethyl Laboratories Basic Information, Area Served and Competitors
Table 204. Bethyl LaboratoriesMajor Business
Table 205. Bethyl Laboratories Anti-CD47 Antibody Product and Services
Table 206. Bethyl Laboratories Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 207. Bethyl Laboratories Recent Developments/Updates
Table 208. Abeomics Basic Information, Area Served and Competitors
Table 209. Abeomics Major Business
Table 210. Abeomics Anti-CD47 Antibody Product and Services
Table 211. Abeomics Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 212. Global Key Players of Anti-CD47 Antibody Upstream (Raw Materials)
Table 213. Anti-CD47 Antibody Typical Customers
LIST OF FIGURE
.
Figure 1. Anti-CD47 Antibody Picture
Figure 2. World Anti-CD47 Antibody Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Anti-CD47 Antibody Total Market Size (2019-2030) & (USD Million)
Figure 4. World Anti-CD47 Antibody Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Anti-CD47 Antibody Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Anti-CD47 Antibody Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Anti-CD47 Antibody Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Anti-CD47 Antibody Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Anti-CD47 Antibody Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Anti-CD47 Antibody Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Anti-CD47 Antibody Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Anti-CD47 Antibody Revenue (2019-2030) & (USD Million)
Figure 13. Anti-CD47 Antibody Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 16. World Anti-CD47 Antibody Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 18. China Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 23. India Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Anti-CD47 Antibody by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Anti-CD47 Antibody Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Anti-CD47 Antibody Markets in 2023
Figure 27. United States VS China: Anti-CD47 Antibody Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Anti-CD47 Antibody Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Anti-CD47 Antibody Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Anti-CD47 Antibody Market Size Market Share by Type in 2023
Figure 31. Monoclonal Antibody
Figure 32. Polyclonal Antibody
Figure 33. World Anti-CD47 Antibody Market Size Market Share by Type (2019-2030)
Figure 34. World Anti-CD47 Antibody Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World Anti-CD47 Antibody Market Size Market Share by Application in 2023
Figure 36. Biotechnology
Figure 37. Medical
Figure 38. University
Figure 39. Others
Figure 40. Anti-CD47 Antibody Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
